4a,10a-Dihydrophenoxathiine | 491856-42-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - Benzoxathioles
• 英文名称: 4a,10a-Dihydrophenoxathiine
• CAS: 491856-42-9
• 化学式: C₁₂H₁₀OS
• 分子量: 202.277
• InChiKey: FGSYTCFCQFQVSG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  34.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4a,10a-Dihydrophenoxathiine 在 水 作用下， 以 乙腈 为溶剂， 反应 0.67h， 以93%的产率得到
  参考文献：
  名称：

  An Efficient and Selective Oxidation of Sulfides and Thiols with Silica-Supported 1,1,3,3-Tetramethylguanidine/Br₂ Complex

  摘要：

  Silica-supported 1,1,3,3-tetramethylguanidine/Br2 complex is an efficient reagent for the selective oxidation of aliphatic and aromatic sulfides to the corresponding sulfoxides and the oxidative coupling of thiols to disulfides in aqueous solution at room temperature in a short reaction time.

  DOI：

  10.1080/10426500902814031

文献信息

• POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY
  申请人：DIC Corporation

  公开号：US20180002276A1

  公开（公告）日：2018-01-04

  In light of requests to reduce or reverse the wavelength dispersion of the birefringence of a phase-retardation film in order to increase the viewing angle of a liquid crystal display, the present invention provides a polymerizable compound that reduces, for example, the likelihood of crystals precipitating in a polymerizable composition including the polymerizable compound and enables the polymerizable composition to have high preservation stability and a polymerizable composition including the polymerizable compound which reduces the likelihood of inconsistencies being formed in a film-like polymer produced by polymerizing the polymerizable composition. Another object of the present invention is to provide a polymer produced by polymerizing the polymerizable composition and an optically anisotropic body including the polymer.

  鉴于要求减少或逆转相位延迟膜的双折射波长色散，以增加液晶显示器的视角，本发明提供了一种可聚合化合物，例如减少聚合物化合物中晶体沉淀的可能性，并使聚合物化合物具有高保存稳定性以及包括减少聚合物化合物聚合产生的膜状聚合物中不一致性的可能性的聚合物化合物。本发明的另一个目的是提供通过聚合聚合物化合物产生的聚合物以及包括该聚合物的光学各向异性体。
• MOENOMYCIN ANALOGS, METHODS OF SYNTHESIS, AND USES THEREOF
  申请人：Kahne Daniel

  公开号：US20110136759A1

  公开（公告）日：2011-06-09

  The present invention provides novel moenomycin analogs as well as pharmaceutical compositions thereof, methods of synthesis, and methods of use in treating an infection by administering an inventive compound to a subject in need thereof. The moenomycin analogs may be prepared synthetically, biosynthetically, or semi-synthetically. The analogs are particularly useful in treating or preventing infections caused by Gram-positive organisms. Certain inventive compounds may have a broader spectrum of coverage, which includes Gram-negative organisms.

  本发明提供了新型的莫诺霉素类似物及其制药组合物，合成方法以及将创新化合物用于治疗感染的方法，通过将创新化合物给予需要治疗的受试者来治疗感染。莫诺霉素类似物可以通过化学合成，生物合成或半合成的方式制备。这些类似物在治疗或预防由革兰氏阳性菌引起的感染中特别有用。某些创新化合物可能具有更广泛的覆盖范围，包括革兰氏阴性菌。
• INHIBITORS OF FATTY ACID AMIDE HYDROLASE, METHODS OF TREATMENT AND METHODS OF PREPARING SAME
  申请人：Infinity Pharmaceuticals, Inc.

  公开号：US20150344503A1

  公开（公告）日：2015-12-03

  The present invention provides compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III). Methods of preparing compounds encompassed by the formulae (I), (II) or (III) are also provided. The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.

  本发明提供了被公式(I)、(II)或(III)所包含的化合物及其制药组合物。本发明还提供了制备被公式(I)、(II)或(III)所包含的化合物的方法。此外，本发明还提供了通过向需要治疗FAAH介导的疾病、紊乱或状况的患者施用公式(I)、(II)或(III)所提供的化合物或其制药组合物的治疗方法。此外，本发明还提供了通过向需要抑制患者的FAAH的患者施用公式(I)、(II)或(III)所提供的化合物或其制药组合物的方法。
• Polymerizable compound and optically anisotropic body
  申请人：DIC Corporation

  公开号：US10647662B2

  公开（公告）日：2020-05-12

  In light of requests to reduce or reverse the wavelength dispersion of the birefringence of a phase-retardation film in order to increase the viewing angle of a liquid crystal display, the present invention provides a polymerizable compound that reduces, for example, the likelihood of crystals precipitating in a polymerizable composition including the polymerizable compound and enables the polymerizable composition to have high preservation stability and a polymerizable composition including the polymerizable compound which reduces the likelihood of inconsistencies being formed in a film-like polymer produced by polymerizing the polymerizable composition. Another object of the present invention is to provide a polymer produced by polymerizing the polymerizable composition and an optically anisotropic body including the polymer.

  鉴于人们要求减少或逆转相减膜双折射的波长色散，以增大液晶显示器的视角，本发明提供了一种可聚合化合物，该化合物可降低包括该可聚合化合物的可聚合组合物中晶体析出的可能性，并使该可聚合组合物具有较高的保存稳定性；还提供了一种包括该可聚合化合物的可聚合组合物，该组合物可降低通过聚合该可聚合组合物生产的膜状聚合物中形成不一致性的可能性。本发明的另一个目的是提供一种通过聚合可聚合组合物生产的聚合物和一种包括该聚合物的光学各向异性体。
• METHODS OF 11C -RADIOLABELLING PHENOTHIAZINE AND PHENO THIAZINE-LIKE COMPOUNDS
  申请人：The University Court of the University of Aberdeen

  公开号：EP1667947B1

  公开（公告）日：2008-08-20